Desvenlafaxine in the treatment of major depressive disorder

Major depressive disorder (MDD) is among the most incapacitating conditions in the world. The emergence of the selective serotonin reuptake inhibitor (SSRI) and serotonin norepinephrine reuptake inhibitors (SNRI) antidepressants has improved the treatment of MDD. Desvenlafaxine succinate (DVS) is th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lourenco, Maria Teresa C, Kennedy, Sidney H
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695227/
https://www.ncbi.nlm.nih.gov/pubmed/19557107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695227/
https://www.ncbi.nlm.nih.gov/pubmed/19557107

Ejemplares similares